Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study Evaluating the Pregnancy Outcomes and Safety of Interrupting Endocrine Therapy for Young Women With Endocrine Responsive Breast Cancer Who Desire Pregnancy

NCT02308085 is registered in ClinicalTrials.gov with ETOP IBCSG Partners Foundation as lead sponsor.

NCT NCT02308085
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02308085 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study Evaluating the Pregnancy Outcomes and Safety of Interrupting Endocrine Therapy for Young Women With Endocrine Responsive Breast Cancer Who Desire Pregnancy
Lead sponsor
ETOP IBCSG Partners Foundation
Phase
Not applicable
Overall status
Active, not recruiting
Start date
December 4, 2014
Completion date
December 31, 2028
Enrollment
518 (actual)
Sites
211

Conditions

As the registry lists them; a condition with its own page is linked.

early breast cancer